分子名 |
货号 |
物种 |
表达系统 |
产品描述 |
纯度 |
特性 |
包装/价格 |
Cetuximab
|
CEB-Y31
|
Mouse
|
Hybridoma
|
Anti-Cetuximab Antibody (AY31) (Non-Neutralizing)
|
|
|
|
Rituximab
|
RIB-Y36
|
Mouse
|
Hybridoma
|
Anti-Rituximab Antibody (AY36) (recommended for ADA assay)
|
|
|
|
Adalimumab
|
ADB-Y19
|
Mouse
|
Hybridoma
|
Anti-Adalimumab Antibody (AY19)
|
|
|
|
Bevacizumab
|
BEB-Y12
|
Mouse
|
Hybridoma
|
Anti-Bevacizumab Antibody (AY12) (recommended for neutralizing assay)
|
|
|
|
FMC63
|
FM3-HPY53
DMF
|
Mouse
|
HEK293
|
PE-Labeled Monoclonal Anti-FMC63 Antibody, Mouse IgG1 (Y45) (Site-specific conjugation) (Preservative free)
|
|
|
|
Spike S2
|
S2N-S86
|
Human
|
CHO
|
Anti-SARS-CoV-2 Spike S2 Antibody, Human IgG4 (AS86)
|
|
|
|
MMAE
|
MME-M5252
|
Mouse
|
HEK293
|
Monoclonal Anti-MMAE&MMAF Antibody, Mouse IgG1 (MALS verified)
|
|
|
|
DXD
|
DXD-M684
|
Mouse
|
HEK293
|
Monoclonal Anti-DXD&Exatecan Antibody, Mouse IgG1 (MALS verified)
|
|
|
|
IgG control
|
DNP-PM1
|
Mouse
|
HEK293
|
PE-Labeled Monoclonal Mouse IgG1 Antibody Isotype Control (Site-specific conjugation)
|
|
|
|
DM-1
|
DM1-Y73
|
Mouse
|
Hybridoma
|
Monoclonal Anti-DM-1&DM-4 Antibody, Mouse IgG1 (MALS verified)
|
|
|
|
G4S linker
|
G4S-PFMY25
|
Rabbit
|
HEK293
|
PE-Labeled Monoclonal Anti-G4S linker Antibody, Rabbit IgG (016) (0.03% Proclin)
|
|
|
|
Glycoprotein/G Protein (RABV)
|
RAG-M305
|
Mouse
|
HEK293
|
Anti-Rabies virus glycoprotein G Antibody, Mouse IgG1 (523-11) (MALS verified)
|
|
|
|
Cetuximab
|
CEB-BY31
|
Mouse
|
Hybridoma
|
Biotinylated Anti-Cetuximab Antibody (AY31) (recommended for PK/PD)
|
|
|
|
Bevacizumab
|
BEB-BY13
|
Mouse
|
Hybridoma
|
Biotinylated Anti-Bevacizumab Antibody (AY13) (recommended for PK/PD)
|
|
|
|
Nucleocapsid protein
|
NUN-CH15
|
Mouse
|
CHO
|
Anti-SARS-CoV-2 Nucleocapsid Antibody, Chimeric mAb, Human IgG1 (AM223) (MALS verified)
|
|
|
|
FMC63
|
FM3-FY45
DMF
|
Mouse
|
Hybridoma
|
FITC-Labeled Monoclonal Anti-FMC63 Antibody, Mouse IgG1 (Y45)
|
|
|
|
CD3
|
CDE-M531
|
Mouse
|
HEK293
|
Monoclonal Anti-Human CD3 Antibody, Mouse IgG1 (SP34-2)
|
|
|
|
IgG control
|
DNP-M1A1
|
Mouse
|
HEK293
|
Mouse IgG1 kappa Antibody Isotype Control
|
|
|
|
CD28
|
GMP-MC2824
DMF
|
Mouse
|
HEK293
|
GMP Monoclonal Anti-Human CD28 Antibody
|
|
|
|
Cetuximab
|
CEB-Y27
|
Mouse
|
Hybridoma
|
Anti-Cetuximab Antibody (AY27) (recommended for ADA assay)
|
|
|
|
Bevacizumab
|
BEB-Y9
|
Mouse
|
Hybridoma
|
Anti-Bevacizumab Antibody (AY9) (recommended for ADA assay)
|
|
|
|
Nucleocapsid protein
|
NUN-CH14
|
Human
|
CHO
|
Anti-SARS-CoV-2 Nucleocapsid Antibody, Human IgG1 (AS95) (MALS verified)
|
|
|
|
FMC63
|
FM3-AY54P1
|
Mouse
|
HEK293
|
APC-Labeled Monoclonal Anti-FMC63 Antibody, Mouse IgG1 (Y45) (Site-specific conjugation)
|
|
|
|
Spike RBD
|
SPD-S298
|
Mouse
|
HEK293
|
Anti-SARS-CoV-2 Spike RBD Antibody, Mouse IgG1 (9A6A11) (XBB.1.5/Omicron Specific) (MALS verified)
|
|
|
|
Spike NTD
|
SPD-M121
|
Mouse
|
HEK293
|
Anti-SARS-CoV-2 Spike NTD Antibody, Chimeric mAb, Human IgG1 (AM121)
|
|
|
|
CD3
|
GMP-MC0323
DMF
|
Mouse
|
HEK293
|
GMP Monoclonal Anti-Human CD3 Antibody (OKT3)
|
|
|
|
His
|
HIS-BVM539
|
Mouse
|
HEK293
|
Biotinylated Anti-His Tag Antibody(AY63), Fab (MALS verified)
|
|
|
|
IFN-gamma
|
IFN-S120
|
Mouse
|
Hybridoma
|
Monoclonal Anti-IFNγ Antibody, Mouse IgG2a (8C5F8)
|
|
|
|
IFN-gamma
|
IFN-S138
|
Mouse
|
Hybridoma
|
Monoclonal Anti-IFNγ Antibody, Mouse IgG1 (13E6H6)
|
|
|
|
IFN-gamma
|
IFN-M414
|
Mouse
|
HEK293
|
Monoclonal Anti-IFNγ Antibody, Human IgG1 (13E6H6)
|
|
|
|